Home > Healthcare > Medical Devices > Medical Supplies > Amniocentesis Needle Market

Amniocentesis Needle Market Share

Report ID: GMI8186
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Amniocentesis Needle Market Share

The amniocentesis needle industry is a competitive arena, featuring a blend of dominant global manufacturers and smaller to medium-sized enterprises, all vying for their share. A pivotal strategy in this market revolves around the consistent introduction of innovative needle designs and safety enhancements, such as adjustable depth stoppers and precision-guided technologies. Industry leaders, wielding significant influence, often spearhead advancements, backed by hefty investments in research and development.

Moreover, maneuvers like mergers, acquisitions, and strategic partnerships play a vital role in solidifying market positions and broadening global footprints, all while adapting to shifting healthcare needs and regulatory landscapes. The market's competitive dynamics are further shaped by an increasing focus on patient safety, a preference for minimally invasive procedures, and the use of premium materials, all of which influence product offerings and bolster trust among healthcare providers.

Amniocentesis Needle Market Companies

Some of the eminent market participants operating in the amniocentesis needle industry include:

Becton, Dickinson and Company
Biopsybell
Cardinal Health
Eurosurgical
Laboratoire CCD
M.D.L
McKesson Corporation
Medax
Medline Industries
Moller Medical
RI.MOS
Roko
Suzhou Leapmed Healthcare Corporation
The Cooper Companies
Vigeo

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of amniocentesis needle reached USD 176.7 million in 2023 and is set to grow at a 4.9% CAGR from 2024 to 2032, driven by the increasing number of amniocentesis procedures.

The amniocentesis procedures segment held a 33.1% market share in 2023, as it serves as a crucial diagnostic tool for identifying genetic anomalies.

The U.S. market was valued at USD 62.6 million in 2023, led by a higher prevalence of congenital disorders.

Key players in the industry include Becton, Dickinson and Company, Biopsybell, Cardinal Health, Eurosurgical, Laboratoire CCD, M.D.L, McKesson Corporation, Medax, Medline Industries, Moller Medical, RI.MOS, and Roko.